CD14 and CSF1R as developmental molecular targets for the induction of osteoarthritis

Meiliang Zheng1, Zheng Li1, Yingfa Feng2

  • 1Department of Orthopedics, The Second Central Hospital of Baoding No. 57 Fanyang Zhong Road, Zhuozhou 072750, Hebei, China.

Abstract

Insights

This study reveals that CD14 and CSF1R are highly expressed in osteoarthritis, suggesting they are potential therapeutic targets for this degenerative joint disease.

Area of Science:

  • * Molecular biology and bioinformatics.
  • * Genomics and transcriptomics.
  • * Osteoarthritis research.

Background:

  • * Osteoarthritis (OA) is a degenerative joint disease primarily affecting articular cartilage.
  • * The roles of CD14 and CSF1R in OA pathogenesis are not well understood.
  • * Clarifying these roles could offer new therapeutic strategies for OA.

Purpose of the Study:

  • * To investigate the involvement of CD14 and CSF1R in osteoarthritis.
  • * To identify key genes and pathways associated with OA.
  • * To explore potential therapeutic targets for OA prevention and treatment.

Main Methods:

  • * Analysis of osteoarthritis datasets (GSE46750, GSE82107) from the Gene Expression Omnibus (GEO) database.
  • * Differential gene expression analysis using the R package limma.
  • * Weighted gene co-expression network analysis (WGCNA), protein-protein interaction (PPI) network construction, and functional enrichment analyses (GO, KEGG, Metascape).
  • * Comparative Toxicogenomics Database (CTD) analysis and miRNA target prediction.

Main Results:

  • * Identified 687 differentially expressed genes (DEGs) primarily enriched in inflammatory response and signaling pathways.
  • * Discovered 20 core genes through PPI network analysis, with CD14 and CSF1R showing high expression in OA synovial tissues.
  • * CTD analysis linked twelve core genes, including CD14 and CSF1R, to inflammation and other related conditions.

Conclusions:

  • * CD14 and CSF1R are significantly upregulated in osteoarthritis.
  • * These genes represent promising therapeutic targets for osteoarthritis.
  • * Further research into CD14 and CSF1R could lead to novel OA treatments.